Company intelligence / Profile preview

Jasmine Angel J

Seoul, South Korea

Ownership: Private
Development stage: Other

Overview

Jasmine Angel J is a South Korean biotechnology company focused on the development of innovative medical aesthetics and regenerative therapies. The company is best known for its Angel J series of skin boosters, which utilize polydeoxyribonucleotide (PDRN) and hyaluronic acid to stimulate tissue repair and collagen production. Their product portfolio targets dermatological indications such as skin aging, scarring, and loss of elasticity. By leveraging advanced formulation technologies, Jasmine Angel J provides high-efficacy, minimally invasive solutions for the global aesthetic medicine market. The company maintains a strong presence in Asia and is expanding its distribution to international healthcare providers.

Therapeutic areas: Dermatology
Modalities: BiologicMedical devicePeptides
Industry: Pharma

Beyond the preview

Go deeper on Jasmine Angel J.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jasmine Angel J.

Explore the full profile